Mallinckrodt PLC resigned from the Pharmaceutical Research and Manufacturers Association on Monday ahead of potential changes to the trade group’s by-laws that could exclude companies that don’t spend significant funds on researching and developing new drugs.
More | Talk | Read It Later | ShareWalgreens Boots Alliance’s chief executive said he expects the drugstore chain’s long-delayed tie-up with Rite Aid to be approved in the coming months. The company’s revenue also fell more than Wall Street anticipated.
More | Talk | Read It Later | ShareKansas’ Republican governor vetoed a bill to expand Medicaid, two days after the state’s GOP-led legislature approved extending eligibility for the program under the Affordable Care Act.
More | Talk | Read It Later | ShareKansas’ Republican governor vetoed a bill to expand Medicaid, two days after the state’s GOP-led legislature approved extending eligibility for the program under the Affordable Care Act.
More | Talk | Read It Later | ShareLawmakers voted to extend Medicaid to cover more than 150,000 additional nondisabled adults under the Affordable Care Act, just days after Republicans in Washington pulled their bill to repeal and replace the law known as Obamacare.
More | Talk | Read It Later | ShareVertex Pharmaceuticals said it would seek regulatory approval for one of its experimental cystic-fibrosis drugs after the treatment helped improve patients’ lung function in late-stage studies.
More | Talk | Read It Later | ShareA growing number of states are considering expanding their Medicaid programs under the Affordable Care Act, after last week’s abrupt collapse of the GOP health bill and a development that could make it harder for Republicans to undo the law in the future.
More | Talk | Read It Later | ShareA New York hospital system tests a new way to use telemedicine, where E.R. doctors examine patients without being in the same room.
More | Talk | Read It Later | SharePresident Donald Trump and GOP lawmakers, seeking to regroup following the collapse of the effort to repeal the Affordable Care Act, have an option for gutting the health law relatively quickly: They could halt billions in payments insurers get under the law.
More | Talk | Read It Later | ShareFDA chief nominee Scott Gottlieb’s changes may pressure generic drug prices, but there are other positives for the sector.
More | Talk | Read It Later | ShareVirginia Republican legislators have blocked Democratic Gov. Terry McAuliffe’s latest attempt to expand Medicaid, this time through a state budget amendment.
More | Talk | Read It Later | ShareMylan NV was hit Monday with a lawsuit alleging the drug company overcharged EpiPen patients.
More | Talk | Read It Later | ShareHouse Speaker Paul Ryan said the Trump administration should continue making payments to insurers under the Affordable Care Act to avoid destabilizing the market.
More | Talk | Read It Later | ShareAn adviser to pension funds invested in hospital company Universal Health Services said it will oppose reelection of a UHS director unless the company promises to overhaul its governance.
More | Talk | Read It Later | ShareThe FDA approved a Genentech multiple-sclerosis drug called Ocrevus, the first treatment for the most severe type of MS.
More | Talk | Read It Later | ShareRegeneron Pharmaceuticals and Sanofi said they will charge $37,000 annually in the U.S. for their newly approved eczema drug, a price the companies said they reached after months of negotiations with pharmacy benefit managers.
More | Talk | Read It Later | ShareBillionaire entrepreneur Elon Musk wants to merge computers with human brains to help people keep up with machines.
More | Talk | Read It Later | ShareA New York hospital system tests a new way to use telemedicine, where E.R. doctors examine patients without being in the same room.
More | Talk | Read It Later | ShareA Canadian research team found low doses of the blood thinner rivaroxaban, marketed as Xarelto from Johnson & Johnson unit Janssen Pharmaceuticals, reduced the risk of blood clot recurrence by about 70% compared with aspirin, without increasing the risk of bleeding.
More | Talk | Read It Later | ShareDemocrats, after playing defense on health care for nearly a decade, are trying to turn the issue to their advantage in next year’s midterm elections, targeting in particular lawmakers who have already voted for the GOP health bill.
More | Talk | Read It Later | ShareTheranos founder Elizabeth Holmes, whose once-$5 billion stake in her blood-testing firm has shriveled amid regulatory and legal challenges, also owes her company about $25 million.
More | Talk | Read It Later | ShareSome doctors say individuals at high risk for skin cancer should have one head-to-toe exam a year .
More | Talk | Read It Later | ShareVice President Mike Pence cast the tiebreaking votes in the Senate on a measure that would enable states to strip some federal funds from Planned Parenthood and other health-care providers.
More | Talk | Read It Later | ShareAn adviser to pension funds invested in hospital company Universal Health Services said it will oppose reelection of a UHS director unless the company promises to overhaul its governance.
More | Talk | Read It Later | ShareA growing number of states are considering expanding their Medicaid programs under the Affordable Care Act, after last week’s abrupt collapse of the GOP health bill and a development that could make it harder for Republicans to undo the law in the future.
More | Talk | Read It Later | ShareSpecialty pharmaceuticals maker Depomed has replaced its chief executive and named two new directors to its board after nearly a year of activist pressure from Starboard Value LP.
More | Talk | Read It Later | ShareSpecialty pharmaceuticals maker Depomed has replaced its chief executive and named two new directors to its board after nearly a year of activist pressure from Starboard Value LP.
More | Talk | Read It Later | ShareMichael Pearson, ex-CEO of Valeant Pharmaceuticals, is suing the embattled drugmaker for refusing to pay him more than 3 million company shares that he said he is owed.
More | Talk | Read It Later | SharePaul Ryan expressed confidence that the Republican health-care plan will pass the House later this week, saying his party’s lawmakers are working to make changes to the bill to address remaining concerns, including providing more assistance to older Americans.
More | Talk | Read It Later | ShareRepublican senators, alarmed by a nonpartisan report showing millions would lose insurance under the GOP health-care plan, warned Tuesday that the bill wouldn’t become law without fundamental changes.
More | Talk | Read It Later | Share